Publication

A comprehensive analysis of the role of stem cell transplantation in mantle cell lymphoma: real-world data from the Korean Society of Blood and Marrow Transplantation registry

Korean Society of Blood and Marrow Transplantation  |  2025;60(1):44  |  Blood Res

Alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma

An S, Hong J, Shin DY, Byun JM, Koh Y, Yoon SS  |  2025;25(1):1910  |  BMC Cancer

Clinical outcomes of low-grade cytomegalovirus DNAemia in hematopoietic stem cell transplantation recipients receiving letermovir prophylaxis

Son JS, Jeong EJ, Jo HJ, et al  |  2025;97(12):e70736  |  J Med Virol

Clonal hematopoiesis: elements associated with clonal expansion and diseases

Ryu G, Koh Y, Jaiswal S, Yoon SS  |  2025;60(1):17  |  Blood Res

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions

Jung SH, Koh Y, Kim MK, et al  |  2025;60(1):9  |  Blood Res

Influence of lifestyle risk factors and genetic predisposition on metabolic syndrome risk in Korean adults

Hwang SY, Rhee TM, Kim CS, et al  |  2025;15(1):24060  |  Sci Rep

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma

Korean Multiple Myeloma Working Party (KMMWP)  |  2025;25(1):204  |  BMC Cancer

Nanoshield-assisted viral gene therapy with induction of non-apoptotic cell death and durable antitumor immunity

Lee SH, Cho Y, Bang S, et al  |  2025;12(41):e07550  |  Adv Sci

Thrombophilia in liver donors: prevalence of protein C or S deficiency in Korean candidates and decision considerations

Lee S, Hong SK, Byun JM, et al  |  2025;39(8):e70265  |  Clin Transplant

Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study

Kim DH, Kong JH, Hong J, et al  |  2025;16:20406207251349361  |  Ther Adv Hematol

Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study

Kim DH, Park T, Hong J, et al  |  2025;104(7):3843-3854  |  Ann Hematol

Real-world effectiveness and safety of intravenous daratumumab in patients with multiple myeloma: a multicenter, observational study from Korea

Koh Y, Yoon SS, Kim K, et al  |  2025;57(3):883-890  |  Cancer Res Treat

Clonal haematopoiesis of indeterminate potential: a risk factor for future exacerbation in patients with COPD

Lee JK, An H, Koh Y, Lee CH  |  2025;11(3):00292-2024  |  ERJ Open Res

Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma

Ng SC, Moon JH, Park SS, et al  |  2025;121(5):670-683  |  Int J Hematol

Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm

Lee JH, Oh SY, Lee TG, et al  |  2025;206(4):1228-1232  |  Br J Haematol

Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma

Kwon S, Park HY, Byun JM, et al  |  2025;104(4):2297-2304  |  Ann Hematol

Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies

Roeker LE, Coombs CC, Shah NN, et al  |  2025;148(2):180-197  |  Acta Haematol

Association of clonal hematopoiesis of indeterminate potential with myocardial characteristic differences in non-ischemic heart failure

Lee J, Hong YJ, Park JH, et al  |  2025;11(4):e42858  |  Heliyon

Efficacy and safety of bispecific T-cell engagers in relapsed/refractory multiple myeloma: a real-world data-based case-controlled study

Choi S, Byun JM, Park SS, et al  |  2025;31(2):74.e1-74.e11  |  Transplant Cell Ther

Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea

Kim DH, Kwon S, Cha S, et al  |  2025;16  |  Ther Adv Hematol

Incidence and characteristics of infectious complications in multiple myeloma patients treated with bispecific antibodies

Park T, Jang S, Koh Y, et al  |  2025;40(20):e86  |  J Korean Med Sci

MG4101, an allogeneic natural killer cell, in patients with relapsed or refractory acute myeloid leukemia: a pilot study

Kim SA, Jung M, Kim H, et al  |  2025;66(2):298-305  |  Leuk Lymphoma

Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study

Ahn HY, An HY, Ryu G, et al  |  2024;45(10):778-790  |  Eur Heart J

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Park C, Lee HS, Kang KW, Lee W, et al  |  2024;15(1):2776  |  Nat Commun

Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms

Yoon H, Dean LS, Jiyarom B, et al  |  2024;14  |  Front Immunol

Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data

Lee G, Lee SM, Lee S, et al  |  2024;25(1):66  |  Genome Biol

Impact of clonal haematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels in general population

Lee H, Song H, Choi SY, et al  |  2024  |  Eur J Prev Cardiol

Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia

Chun C, Byun JM, Cha M, et al  |  2024;8:1379-1395  |  Nat Biomed Eng

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation

Park W, Byun JM, Hong J, et al  |  2023  |  Ann Hematol

Mitigating the BFL-1 mediated antiapoptotic pathway in diffuse large B cell lymphoma by inhibiting HDACs

Park E, Lee C, Park J, et al  |  2023;64(1):205-216  |  Leuk Lymphoma

Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

Shin J, Lee JY, Lee GW, et al  |  2023;202(6):e54-e57  |  Br J Haematol

Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma

Koh Y, Kim H, Joo SY, et al  |  2023;21(1):730  |  J Transl Med

A phase II study to evaluate the efficacy of bortezomib in combination with thalidomide in treatment-naive Waldenstrom macroglobulinemia patients

Byun JM, Shin J, Kim SA, et al  |  2023  |  Cancer Res Treat

Phase 1 study: safety and efficacy of an ex vivo-expanded allogeneic natural killer cell (MG4101) with rituximab for relapsed/refractory B cell non-Hodgkin lymphoma

Yoon DH, Koh Y, Jung M, et al  |  2023;29(4):253  |  Transplant Cell Ther

Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes

Song S, Koh Y, Kim S, et al  |  2023;15(1):107  |  Genome Med

Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy

Yun JK, Kim S, An H, et al  |  2023;15(1):111  |  Genome Med

Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma

Kim DW, Byun JM, Lee JO, et al  |  2023;8(2)  |  JCI Insight

Pirtobrutinib in covalent Bruton tyrosine kinase inhibitor pretreated mantle-cell lymphoma

Wang ML, et al  |  2023;41:3988-3997  |  J Clin Oncol

Clonal hematopoiesis and acute ischemic stroke outcomes

Lee EJ, An HY, Lim J, et al  |  2023;94(5):836-847  |  Ann Neurol

Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia

Liu J, Min S, Kim D, et al  |  2023;37:1638-1648  |  Leukemia

Single-cell transcriptome analysis reveal distinct gene expression signatures of severe COVID-19 in the presence of clonal hematopoiesis

Choi B, Kang CK, Park S, et al  |  2022  |  Exp Mol Med

Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: analysis of 3 prospective cohort studies in Korea

Song H, Koh Y, Rhee TM, et al  |  2022;348:16-24  |  Atherosclerosis

Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment

Lee C, Lee S, Park E, et al  |  2022;14(1):111  |  Genome Med

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease

Byun JM, Min CK, Kim K, et al  |  2022;15(1):150  |  J Hematol Oncol

The presence of clonal hematopoiesis is negatively associated with diabetic peripheral neuropathy in type 2 diabetes

Oh TJ, Song H, Koh Y, et al  |  2022;37(2):243-248  |  Endocrinol Metab

Clonal hematopoiesis is associated with risk of severe Covid-19

Bolton K, Koh Y, Foote M, et al  |  2021;12(1):5975  |  Nat Commun

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Moreau P, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, et al  |  2021;397(10292):2361-2371  |  Lancet

Synergistic effect of alectinib and everolimus on ALK-positive anaplastic large cell lymphoma growth inhibition

Kim D, Koh Y, Yoon SS  |  2020;40(3):1395-1403  |  Anticancer Res

MED-TMA: a clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method

Yoon J, Lee S, Sun CH, et al  |  2020;193:154-159  |  Thromb Res

The molecular pathogenesis of trichilemmal carcinoma

Ha JH, Lee C, Lee KS, et al  |  2020;20(1):516  |  BMC Cancer

Proper read filtering method to adequately analyze whole-transcriptome sequencing and RNA based immune repertoire sequencing data for tumor milieu research

Lee S, Song S, Yoon SS, et al  |  2020;12  |  Cancers (Basel)

Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer

Ku J, Kim R, Kim D, et al  |  2020;3:630  |  Commun Biol

VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with sunitinib

Koh Y, Lee HE, Im SA, et al  |  2011;20(3):143-147  |  Diagn Mol Pathol

Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients

Kim I, Koh Y, Yoon SS, et al  |  2013;88(1):10-15  |  Am J Hematol

Application of array comparative genomic hybridization in chronic myeloid leukemia

Park S, Koh Y, Jung SH, Chung YJ  |  2013;973:55-68  |  Methods Mol Biol

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

Koh Y, Lim HY, Ahn JH, et al  |  2013;24(4):1026-1031  |  Ann Oncol

Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation

Koh Y, Kim I, Shin DY, et al  |  2012;18(1):37-43  |  Biol Blood Marrow Transplant

The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use

Koh Y, Lee HE, Oh DY, et al  |  2012;42(11):1020-1027  |  Jpn J Clin Oncol

Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors

Koh Y, Kim DW, Kim TM, et al  |  2011;6(5):905-912  |  J Thorac Oncol

EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma

Koh Y, Jang B, Jeon YK, et al  |  2011;41(4):548-554  |  Jpn J Clin Oncol

GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization

Koh Y, Kim DY, Park SH, et al  |  2010;203(2):215-221  |  Cancer Genet Cytogenet

Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8

Koh Y, Kim I, Bae JY, et al  |  2010;40(11):1037-1045  |  Jpn J Clin Oncol

Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA)

Koh Y, Lee HR, Song EY, et al  |  2010;34(10):1344-1350  |  Leuk Res

Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

Koh Y, Kim I, Yoon SS, et al  |  2010;89(7):725-731  |  Ann Hematol

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer

Koh Y, Jang B, Han SW, et al  |  2010;5(3):320-325  |  J Thorac Oncol

Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide

Koh Y, Bang SM, Lee JH, et al  |  2010;89(2):201-206  |  Ann Hematol

Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma

Koh Y, Kim TM, Jeon YK, et al  |  2009;20(8):1414-1419  |  Ann Oncol

Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway

Koh Y, Park J, Ahn KS, et al  |  2009;88(11):1089-1097  |  Ann Hematol

Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype

Koh Y, Park J, Bae EK, et al  |  2009;90(1):1-5  |  Int J Hematol

Establishment of cell lines from both myeloma bone marrow and plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a single patient

Koh Y, Jung WJ, Ahn KS, Yoon SS  |  2014;2014:510408  |  Biomed Res Int

Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients

Koh Y, Lee SY, Kim I, et al  |  2014;74(3):653-657  |  Cancer Chemother Pharmacol

Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia

Park H, Youk J, Kim I, et al  |  2016;95(11):1777-1786  |  Ann Hematol

A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data

Youk J, Koh Y, Kim JW, et al  |  2016;51(1):17-22  |  Blood Res

Detection of a distinctive genomic signature in rhabdoid glioblastoma, a rare disease entity identified by whole exome sequencing and whole transcriptome sequencing

Koh Y, Park I, Sun CH, et al  |  2015;8(4):279-287  |  Transl Oncol

A randomized, multicenter, phase II study of cetuximab with docetaxel and cisplatin as induction chemotherapy in unresectable, locally advanced head and neck cancer

Lee KW, Koh Y, Kim SB, et al  |  2015;20(10):1119-1120  |  Oncologist

BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors

Byun JM, Koh Y, Shin DY, et al  |  2017;102(5):e187-e190  |  Haematologica

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy

Park H, Youk J, Shin DY, et al  |  2019;19(1):358  |  BMC Cancer

Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus)

Song H, Lim Y, Im H, et al  |  2019;9(1):3465  |  Sci Rep

Body cavity-based lymphoma in a country with low human immunodeficiency virus prevalence: a series of 17 cases from the Consortium for Improving Survival of Lymphoma

Shin J, Ko YH, Oh SY, et al  |  2019  |  Cancer Res Treat

Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia

Ock CY, Seo H, Kim DY, et al  |  2019;60(7):1775-1781  |  Leuk Lymphoma

Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors

Kim SA, Lee J, Moon JH, et al  |  2019;98(2):501-510  |  Ann Hematol

FDG PET for evaluation of bone marrow status in T-cell lymphoma

Koh Y, Lee JM, Woo GU, et al  |  2019;44(1):4-10  |  Clin Nucl Med

RTK-RAS pathway mutation is enriched in myeloid sarcoma

Choi M, Jeon YK, Sun CH, et al  |  2018;8(5):43  |  Blood Cancer J

Identification of novel functional variants of SIN3A and SRSF1 among somatic variants in acute myeloid leukemia patients

Min JW, Koh Y, Kim DY, et al  |  2018;41(5):465-475  |  Mol Cells

Truncation of MYH8 tail in AML: a novel prognostic marker with increased cell migration and epithelial-mesenchymal transition utilizing the RAF/MAPK pathway

Park H, Kim D, Kim D, et al  |  2019  |  Carcinogenesis

Oncogenic effects of germline variants in lysosomal storage disease genes

Shin J, Kim D, Kim HL, et al  |  2019  |  Genet Med

Comparison of quality of life and health behaviors in survivors of acute leukemia and the general population

Suh KJ, Shin DY, Kim I, et al  |  2019;98(10):2357-2366  |  Ann Hematol

The temporal sequence and the differences in somatic mutation acquisition determines clinical behaviors of JAK2-positive myeloproliferative neoplasms

Byun JM, Song S, Koh Y, Yoon SS, Kim D  |  2019;39(11):6273-6282  |  Anticancer Res